AGS Health(R) CEO Patrice Wolfe Named one of the Becker's Healthcare 'Top Women to Know in Health IT'
Wolfe has been at the helm of AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., for nearly six years. During her tenure, the company has evolved into a market leader in technology-led RCM solutions, strengthening its capabilities through strategic acquisitions and the organic development of proprietary technologies.
Central to Wolfe's leadership is a bold vision for a frictionless revenue cycle powered by a hybrid intelligence model that seamlessly blends human expertise with the speed, scale, and precision of artificial intelligence (AI). This model enhances human decision-making with AI's analytical power, creating a synergistic system designed to prioritize outcomes over narrowly defined metrics and point solutions.
'Healthcare leaders are seeking a more strategic approach to revenue cycle management-one that goes beyond transactional efficiency and focuses on delivering measurable financial and clinical outcomes,' said Wolfe. 'That's the philosophy behind our hybrid intelligence model. Our clients view us not merely as a vendor but as a long-term strategic partner. The success of our solutions is measured by the tangible impact we deliver, whether that's increasing cash flow, reducing denials, or improving the patient financial experience.'
Under Wolfe's leadership, AGS Health has introduced a series of transformative advancements aimed at modernizing and optimizing revenue cycle operations. Key innovations include the deployment of agentic automation, autonomous medical coding solutions, and hybrid intelligence solutions for front-end financial clearance and prior authorization processes. The company has also developed proprietary workflow orchestration tools that enhance the efficiency, accuracy, and decision-making capabilities of its service teams through intelligent automation and real-time data insights.
Wolfe also spearheaded the company's geographic expansion into Mexico and the Philippines, broadening customers' access to diverse, highly skilled talent pools that are uniquely suited for clinical administrative support roles.
In recognition of its strong workplace culture and employee engagement, AGS Health earned Great Place to Work ® certification in India, the United States, and the Philippines. The company also achieved significant industry recognition, including being named a Leader in Everest Group's Medical Coding Operations PEAK Matrix ® Assessment and receiving four consecutive Leader and Star Performer designations in Everest Group's RCM Operations evaluations.
Additional accolades under Wolfe's tenure include being named 'Most Improved Services Solution – Best in KLAS: Software & Services,' earning the KLAS Research and Censinet Cybersecurity Transparent designation, and receiving the UiPath AI25 Award along with the Data Security Council of India (DSCI) Excellence Award for Best Security Practices in an Organization.
'I am honored to be among such an elite group of women who are reshaping the healthcare industry,' says Wolfe. 'But I did not achieve this honor alone; credit extends to the exceptional AGS Health team, which shares my commitment to leveraging the latest technologies to deliver exceptional quality to our healthcare customers.'
The women leaders recognized on Becker's list, curated by the editorial team from nominations submitted across the healthcare ecosystem, utilize technology to drive meaningful change by streamlining administrative processes, enhancing care delivery, standardizing workflows, and elevating overall system efficiency. In its announcement, Becker's Healthcare stated its pride in honoring trailblazing women in health IT for their unwavering commitment to improving healthcare, adding that their leadership and innovation are essential to the continued success of their organizations and the healthcare industry.
The complete list of Women in Health IT to Know can be accessed here.
About AGS Health
AGS Health is more than a revenue cycle management company-we're a strategic partner for growth. Our distinctive methodology blends award-winning services with intelligent automation and high-touch customer support to deliver peak end-to-end revenue cycle performance and an empowering patient financial experience.
We employ a team of 15,000 highly trained and college-educated RCM experts who directly support more than 150 customers spanning a variety of care settings and specialties, including nearly 50% of the 20 most prominent U.S. hospitals and 40% of the nation's 10 largest health systems. Our thoughtfully crafted RCM solutions deliver measurable revenue growth and retention, enabling customers to achieve the revenue to realize their vision.
# # #
Media Contact:
Liz Goar
NPC Creative Services
liz@npccs.com
SOURCE: AGS Health
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
24 minutes ago
- Associated Press
Say Goodbye to Itchy Skin: SilverCeuticals Launches Breakthrough FDA-Registered Eczema Therapy & Skin Relief Cream
The natural solution to skin irritation - Powered by science, nature, and silver. LINDON, UTAH / ACCESS Newswire / August 19, 2025 / SilverCeuticals Inc, a leader in advanced nano silver health and wellness solutions, is proud to announce the launch of its newest FDA-registered Over the Counter (OTC) drug product: Eczema Therapy & Skin Relief Cream. Designed to deliver fast, effective relief for irritated skin, this revolutionary formula combines FDA-approved colloidal oatmeal with SilverCeuticals' AG4O4 Nano Silver Therapy & Skin Relief Cream A bottle of SilverCeuticals Eczema Therapy & Skin Relief Cream Clinically backed, naturally soothing, and powerfully effective. Visible results may be seen in just 1-2 days. 'It's time for eczema relief products that actually work, without harsh chemicals,' said Dr. Keith Moeller, CEO of SilverCeuticals. 'This product is safe, highly moisturizing, and supports fast recovery for children and adults who suffer from eczema and other skin irritations. We've included ingredients that not only meet FDA standards but also align with the values of natural health practitioners.' This ultra-hydrating cream features a powerful blend of ingredients, including: Unlike many conventional treatments, this formulation is free from steroids, parabens, fragrances, and other harsh chemicals - making it ideal for sensitive skin. It also provides relief beyond eczema for other common skin issues, such as: Packaged in a TSA-compliant 3.4 oz. airless pump bottle, it's perfect for travel and daily use. 'One in five children experiences eczema and our goal is to eliminate their irritation and suffering without the harmful side effects. We believe healing should be fast, safe, and accessible.' added Dr. Moeller. 'After just two days, my son's eczema patches had nearly disappeared. Nothing has ever worked this fast and without steroids.' - Sarah L., mother of a 6-year-old eczema sufferer AG4O4 Nano Silver has been shown in lab studies to support the body's natural healing process and helps reduce inflammation at the source. Experience real relief! Order your first bottle today at Use the coupon code 'Heal' to receive a 15% discount at checkout. Also available through practitioners, professionals, and affiliates. For media or wholesale inquiries, contact SilverCeuticals at 385-212-4044. Contact InformationKirk Moeller CMO 8016364851 SOURCE: SilverCeuticals Inc press release
Associated Press
40 minutes ago
- Associated Press
SSSTC Launches World's First Industrial M.2 SSD Featuring KIOXIA's 8th generation BiCS FLASH™ Technology and PCIe® 5.0 Interface
TAIPEI, TAIWAN - Media OutReach Newswire - 19 August 2025 - Solid State Storage Technology Corporation (SSSTC) proudly announces the launch of the SSSTC CA8 Series, the world's first industrial M.2 SSD built with BiCS FLASH™ generation 8 3D flash memory technology and a PCIe® Gen5 x4 interface. Offered in the industry-standard M.2 2280 form factor, the SSSTC CA8 Series is available in 512 GB, 1 TB, 2 TB, and 4 TB capacities. The SSSTC CA8 Series is the world's first industrial M.2 SSD to combine KIOXIA's 8th-generation BiCS FLASH™ 3D NAND technology with PCIe Gen5 x4 interface, image credit SSSTC. The SSSTC CA8 Series complies with PCIe® 5.0 and NVMe™ 2.0, supporting ultra-high-speed data access with transfer rates up to 32 GT/s per-lane—doubling the throughput of PCIe® 4.0 interface. With SLC caching, the SSSTC CA8 Series achieves sequential read speeds of up to 14,000 MB/s and write speeds up to 12,000 MB/s, along with random performance of up to 2,000K IOPS (read) and 1,600K IOPS (write) — making it one of the fastest industrial SSDs on the market. At its core is KIOXIA's 8th generation BiCS FLASH™ 218-layer 3D TLC NAND Flash Memory with CMOS directly Bonded to Array (CBA) wafer bonding technology , enabling a 20% improvement in write performance, over 10% reduction in read latency, and up to 30% better power consumption. These enhancements make the SSSTC CA8 Series a critical enabler for data-intensive edge computing and high-performance industrial workloads. Designed for long-term reliability and broad system compatibility, the SSSTC CA8 Series features: • MTBF exceeding 3 million hours • Wide operating temperature range (0 °C to 85 °C) • Supply longevity of 5 to 10 years Its robust durability and consistent performance make it ideal for demanding applications such as AIoT, factory automation, networking, in-vehicle systems, and edge servers—especially those involving Edge AI workloads. To ensure data integrity and system resilience, the CA8 Series includes: • High-performance ECC • Power Loss Notification (PLN) to prevent data corruption during unexpected shutdowns • AES-256 encryption and TCG Opal support for advanced data protection As a subsidiary of KIOXIA, SSSTC is committed to delivering highly stable, high-performance SSD solutions to global enterprise and industrial customers. The SSSTC CA8 Series is scheduled to enter mass production in Q4 2025. For more information, please visit the SSSTC website Hashtag: #SSSTC The issuer is solely responsible for the content of this announcement. About Solid State Storage Technology Corporation (SSSTC) SSSTC, a subsidiary of KIOXIA—one of the world's leading memory solution providers—is dedicated to the development, manufacturing, and sales of solid-state drives (SSDs). By combining its in-house R&D capabilities with KIOXIA's cutting-edge NAND flash technology, SSSTC consistently delivers high-quality, high-reliability industrial-grade and enterprise-grade SSD solutions to customers worldwide. Trademark Notice: -NVMe is a registered or unregistered trademarks of NVM Express, Inc. in the United States and other countries. -PCIe is a registered trademark of PCI-SIG. -Other company names, product names and service names may be trademarks of third-party companies.
Associated Press
41 minutes ago
- Associated Press
Poriferous, LLC Achieves Coveted EU MDR Regulatory Certification for Porous Polyethylene Implants
Newnan, GA August 18, 2025 --( )-- Poriferous LLC., industry innovator in high density porous polyethylene craniomaxillofaical implants, announces it has successfully received its EU Medical Device Regulation (MDR) certification. This regulatory authorization has been achieved by only 15% of medical device companies, putting Poriferous and their SU-POR® line of products in esteemed company. The certification testifies to Poriferous' rigorous standards for safety and quality, ensuring their devices have no negative impacts on human health. The EU MDR replaces the former Medical Device Directive (MDD) and establishes a more intensive and transparent regulatory framework with greater long-term viability. It emphasizes post-market surveillance, implements Unique Device Identifications (UDIs) to track devices in the supply chain, and specifically includes devices that may not have a strictly medical function, such as implants used in cosmetic surgeries. Because of these additions to the regulatory standards, Poriferous' SU-POR Implants are now included in this new, enhanced system for regulatory quality. The MDR certification covers the entire Poriferous catalogue of SU-POR Implants, reaffirming Poriferous' mission of providing quality healthcare and innovation to surgeons and patients around the world. Contact Information: Poriferous, LLC Krista Bradstreet 470-699-8608 Contact via Email Read the full story here: Poriferous, LLC Achieves Coveted EU MDR Regulatory Certification for Porous Polyethylene Implants Press Release Distributed by
